Journal of Clinical Psychopharmacology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.9 | Q2 | 60.1% | 0.523 | Q3 | 62.5% |
| 2024 | 2.8 | Q2 | 63.5% | 0.725 | Q2 | 74.7% |
| 2023 | 2.9 | Q2 | 63.6% | 0.728 | Q2 | 76.8% |
| 2022 | 2.9 | Q3 | 57.1% | 0.641 | Q2 | 74.1% |
| 2021 | 3.1 | Q3 | 55.9% | 0.679 | Q2 | 76.5% |
| 2020 | — | — | 0.786 | Q2 | 79.3% | |
| 2019 | — | — | 0.951 | Q2 | 84.5% | |
| 2018 | — | — | 0.919 | Q2 | 82.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0271-0749
ISSN
1533-712X
country
UScoverage
1981-2026